colesevelam hydrochloride

FDA Drug Profile — colesevelam hydrochloride, COLESEVELAM HYDROCHLORIDE, Welchol

colesevelam hydrochloride is listed in the FDA National Drug Code directory with 9 NDC codes, marketed under brand names including colesevelam hydrochloride, COLESEVELAM HYDROCHLORIDE, Welchol. Available dosage forms: tablet, film coated, tablet, for suspension.

Drug details

Generic Name
colesevelam hydrochloride
Brand Names
colesevelam hydrochloride, COLESEVELAM HYDROCHLORIDE, Welchol
Application Number
ANDA203480
Sponsor
A-S Medication Solutions
NDC Codes
9
Dosage Forms
TABLET, FILM COATED, TABLET, FOR SUSPENSION
Routes
ORAL
Active Ingredients
COLESEVELAM HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Colesevelam hydrochloride is a bile acid sequestrant indicated as an adjunct to diet and exercise to: reduce elevated low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia ( 1.1 ). reduce LDL-C levels in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia (HeFH), unable to reach LDL-C target levels despite an adequate trial of diet and lifestyle modification ( 1.1 ). Limitations of Use ( 1.3 ): Do not use for treatment of type 1 diabetes or for diabetic ketoacidosis. Not studied in Fredrickson Type I, III, IV, and V dyslipidemias 1.1 Primary Hyperlipidemia Colesevelam hydrochloride for oral suspension is indicated as an adjunct to diet and exercise to reduce elevated low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia. Colesevelam hydrochloride for oral suspension is indicated to reduce LDL-C levels in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia (HeFH) who are unable to reach LDL-C target levels despite an adequate trial of dietary therapy and lifestyle modification. 1.3 Limitations of Use Colesevelam hydrochloride should not be used for the treatment of type 1 diabetes or for the treatment of diabetic ketoacidosis. Colesevelam hydrochloride has not been studied in Fredrickson Type I, III, IV, and V dyslipidemias.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.